Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease cholangitis
Phenotype C0009402|colorectal cancer
Sentences 4
PubMedID- 23665966 We performed a systematic review and meta-analysis of studies evaluating the effect of udca on the risk of ibd-associated colorectal neoplasia (crn) (defined as colorectal cancer and/or dysplasia) in patients with primary sclerosing cholangitis with concomitant ibd (psc-ibd).
PubMedID- 25636976 colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
PubMedID- 22221173 Conclusions: long-term high dose ursodeoxycholic acid does not prevent colorectal cancer or dysplasia in patients with primary sclerosing cholangitis-associated inflammatory bowel disease.
PubMedID- 26061393 Background: histomorphology of colitis-associated colorectal cancer (cac) in patients with primary sclerosing cholangitis (psc) remains to be systemically characterized and prognosis in these patient needs to be further defined.

Page: 1